TrialEuropean journal of nuclear medicine and molecular imaging2021

Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.

Silvia Nicolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.